Press Releases/IR - Page 1 | TalkMarkets
All Posts > Content under Press Releases/IR
1 to 16 of 469 Posts
1 2 3 ... 30
Aspen Group, Inc. Prices Underwritten Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, April 19, 2018 9:08 AM EDT
Aspen Group, Inc. a post-secondary education company, today announced the pricing of an underwritten public offering of 2,800,000 shares of its common stock at a price of $7.15 per share.
In this article: ASPU
Read
Alibaba To Acquire Full Ownership Of China Online Delivery Platform Ele.me
Article By: Business Wire
Monday, April 2, 2018 4:35 AM EDT
Alibaba Group Holding Limited announced today that the company will acquire all outstanding shares that it does not already own in Ele.me, in a transaction that implies the enterprise value of Ele.me at US$9.5 billion.
In this article: BABA
Read
Cesca Therapeutics Announces Registered Direct Offering
Article By: NASDAQ GlobeNewswire
Monday, March 26, 2018 11:10 AM EDT
Cesca Therapeutics Inc. announced that it has entered into definitive purchase agreements with certain institutional investors to sell in a registered direct offering 609,636 shares of its common stock at a purchase price of $2.27 per share.
In this article: KOOL
Read
Leap Therapeutics Announces Pricing Of $14 Million Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Friday, March 23, 2018 9:52 AM EDT
Leap Therapeutics, Inc. today announced the pricing of an underwritten public offering of 1,866,667 shares of its common stock at a public offering price of $7.50 per share.
In this article: LPTX
Read
Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
Article By: NASDAQ GlobeNewswire
Thursday, March 22, 2018 10:23 AM EDT
Accelerate Diagnostics, Inc. today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of convertible senior notes due 2023.
In this article: AXDX
Read
Invuity Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 15, 2018 8:42 PM EDT
Invuity, Inc. today announced the pricing of its public offering of 6,200,000 shares of its common stock at a price to the public of $3.50 per share.
In this article: IVTY
Read
La Jolla Pharmaceutical Company Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 15, 2018 2:17 PM EDT
La Jolla Pharmaceutical Company today announced the pricing of its underwritten public offering of 3,400,000 shares of its common stock at a price to the public of $29.50 per share.
In this article: LJPC
Read
Black Knight Announces Pricing Of Secondary Offering Of Common Stock And Repurchase Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 15, 2018 2:00 AM EDT
Black Knight, Inc. today announced the pricing of the previously announced underwritten public offering of 8,000,000 shares of the Company’s common stock at a public offering price of $49.00.
In this article: BKI
Read
Invuity Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Wednesday, March 14, 2018 9:10 PM EDT
Invuity, Inc. today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.
In this article: IVTY
Read
BiondVax Appoints CRO To Conduct Pivotal Clinical Efficacy Phase 3 Trial Of Its Novel Universal Flu Vaccine Candidate
Article By: PR Newswire
Tuesday, March 13, 2018 9:27 AM EDT
BiondVax Pharmaceuticals developer of the Universal Flu Vaccine candidate M-001, announced today the signing of a Master Service Agreement with a contract research organization to conduct the first pivotal, clinical efficacy, Phase 3 trial of M-001.
In this article: BVXV
Read
Global Blood Therapeutics Announces Full Exercise Of Underwriter’s Option To Purchase Additional Shares
Article By: NASDAQ GlobeNewswire
Monday, March 12, 2018 12:45 PM EDT
Global Blood Therapeutics, Inc. today announced that the underwriter of its previously announced underwritten public offering has exercised in full its option to purchase an additional 600,000 shares of GBT’s common stock.
In this article: GBT
Read
Corvus Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 8, 2018 9:20 PM EDT
Corvus Pharmaceuticals, Inc. today announced the pricing of an underwritten public offering of 7,058,824 shares of its common stock at a price to the public of $8.50 per share.
In this article: CRVS
Read
Global Blood Therapeutics Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, March 8, 2018 5:40 PM EDT
Global Blood Therapeutics, Inc. today announced a registered offering of 3,500,000 shares of its common stock.
In this article: GBT
Read
Superconductor Technologies Announces Registered Direct Offering Priced At-The-Market
Article By: NASDAQ GlobeNewswire
Wednesday, March 7, 2018 8:10 AM EDT
Superconductor Technologies Inc. announced that it has entered into a definitive purchase agreement with an institutional investor to purchase in a registered direct offering priced at-the-market 1,581,000 registered shares of its common stock.
In this article: SCON
Read
Transunion Announces Pricing Of Secondary Offering Of 19,889,564 Shares Of Common Stock
Article By: NASDAQ GlobeNewswire
Tuesday, March 6, 2018 8:01 AM EDT
TransUnion announced the pricing of the underwritten secondary offering by certain of its stockholders of 19,889,564 shares of common stock of the Company.
In this article: TRU
Read
Endocyte Announces Closing Of Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Friday, March 2, 2018 9:35 PM EDT
Endocyte, Inc. announced today the closing of an underwritten registered public offering of 20,535,714 shares of its common stock.
In this article: ECYT
Read
1 to 16 of 469 Posts
1 2 3 ... 30